Major Histocompatibility Complex class II-swine influenza Hemagglutinin H1 epitope complex (MHC II-H1 HA epitope)

The Major Histocompatibility Complex class II-swine influenza Hemagglutinin H1 epitope complex is a specialized molecular assembly consisting of a peptide fragment from the H1-subtype influenza Hemagglutinin protein bound to an MHC class II molecule (1). This complex is primarily displayed on the surface of professional antigen-presenting cells, such as dendritic cells and B cells, where it serves as the primary ligand for CD4+ T-cell receptors (2). The recognition of this complex is essential for the induction of T-cell-dependent B-cell responses, leading to the production of neutralizing antibodies against the influenza virus (3). In the context of swine influenza, these epitopes are critical targets for vaccine design, as they must be conserved enough to provide cross-protection against drifting viral strains (4). Therapeutic strategies, including the use of novel adjuvants and mRNA vaccines, aim to maximize the presentation of these epitopes to ensure a robust and durable immune response (5). However, improper targeting or presentation can lead to complications such as vaccine-associated enhanced respiratory disease (VAERD), particularly in swine models (6).

Other names

MHC II-HA complexpMHCII-H1SLA class II-HA epitopeHLA-DR-H1 HA epitopeHemagglutinin H1 epitope-MHC II complex

The complex acts as a ligand for the T-cell receptor (TCR) on CD4+ T cells, initiating a signaling cascade that leads to T-cell proliferation, cytokine secretion, and coordination of the adaptive immune response.